1. Therapeutic Perspective of Temozolomide Resistance in Glioblastoma Treatment
    Qin Xia et al, 2021, Cancer Investigation CrossRef
  2. A case report of targeted therapy with apatinib in a patient with recurrent high grade glioma
    Xiuping Ding et al, 2018, Medicine CrossRef
  3. Glioblastoma stem‐like cells secrete the pro‐angiogenic VEGF‐A factor in extracellular vesicles
    Lucas Treps et al, 2017, Journal of Extracellular Vesicles CrossRef
  4. Inhibitory member of the apoptosis-stimulating protein of p53 is overexpressed in bladder cancer and correlated to its progression
    Ziyu Wu et al, 2017, Medicine CrossRef
  5. High expression of VEGF and PI3K in glioma stem cells provides new criteria for the grading of gliomas
    LEI WANG et al, 2016, Experimental and Therapeutic Medicine CrossRef
  6. IDH1 mutation diminishes aggressive phenotype in glioma stem cells
    Qi Yao et al, 2017, International Journal of Oncology CrossRef
  7. Engineering antibody and protein therapeutics to cross the blood–brain barrier
    Peng Zhao et al, 2022, Antibody Therapeutics CrossRef
  8. Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
    Olivia G. Taylor et al, 2019, Frontiers in Oncology CrossRef
  9. Downregulation of SIRT6 is associated with poor prognosis in patients with non-small cell lung cancer
    Bojin Zhu et al, 2018, Journal of International Medical Research CrossRef
  10. Overexpression of the Kininogen-1 inhibits proliferation and induces apoptosis of glioma cells
    Jinfang Xu et al, 2018, Journal of Experimental & Clinical Cancer Research CrossRef
  11. In vivo C6 glioma models: an update and a guide toward a more effective preclinical evaluation of potential anti-glioblastoma drugs
    Safura Pournajaf et al, 2024, Reviews in the Neurosciences CrossRef